Mylan (Taiwan) Ltd clinical trials

Acquired by Viatris Inc., Nov 16, 2020 · source ↗

The registry lists 1 studies whose lead sponsor is Mylan (Taiwan) Ltd. 0 are recruiting or about to start. Per ClinicalTrials.gov, last updated May 2, 2022.

Before and after it joined Viatris Inc.

First submitted before Mylan (Taiwan) Ltd became part of Viatris Inc.: 0
First submitted after Mylan (Taiwan) Ltd became part of Viatris Inc.: 1
Unclear, or no submission date: 0

By the date each study was first submitted to the registry. The registry lists today's sponsor name and keeps no history, so this says when a study was filed, not who filed it.

Status

Completed: 1

Phase

Phase 4: 1

Where

Taiwan: 1

Registry sponsor names on this page

Mylan (Taiwan) Ltd1 study

Something wrong with this grouping? Tell us on the Viatris Inc. page.

Studies

Recruiting first, then most recently updated. Showing 1 of 1. All Viatris Inc. studies →

Efficacy and Safety of Ricovir® in Maintaining Durability of Viral Response in Chronic Hepatitis B Patients Who Have Been Treated With Viread® and Have Undetectable HBV DNA in SerumCompletedNCT05355467Phase 4
Sponsor listed in the registry: Mylan (Taiwan) Ltd · First submitted after Mylan (Taiwan) Ltd became part of Viatris Inc.